Posted by cpallen79 on July 30, 2004, at 12:21:43
In reply to Re: CRF1 antagonists back in clinical trials, posted by SLS on July 28, 2004, at 22:55:19
I have to admit that the CRF idea is pretty exciting. From my understanding (again I'm no whiz at science) they stop the effects of cortisol, and that could possibly be of huge benefit in preventing depressive episodes. Please correct me if I'm wrong.
> > Neurocrine, Inc. in alliance with GSK will push forward with a Phase I trial of a CRF1 antagonist compound by year-end 2004.
>
>
> How long does it take for a drug to go from Phase I to final approval?
>
>
> - Scott
poster:cpallen79
thread:371835
URL: http://www.dr-bob.org/babble/20040730/msgs/372354.html